Prodromic Inflammatory–Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer’s Disease
暂无分享,去创建一个
[1] N. Ip,et al. Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology , 2023, Journal of neurochemistry.
[2] A. Macpherson,et al. Boundaries and integration between microbiota, the nervous system, and immunity. , 2023, Immunity.
[3] C. Morén,et al. Antioxidant Therapeutic Strategies in Neurodegenerative Diseases , 2022, International journal of molecular sciences.
[4] M. De la Fuente,et al. Prematurely aging female mice improve their behavioural response, immunity, redox state, and lifespan after a short social interaction with non-prematurely aging mice , 2022, Biogerontology.
[5] P. Madhavan,et al. A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer’s disease , 2022, The International journal of neuroscience.
[6] T. Saleh,et al. Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease , 2022, Antioxidants.
[7] Lin F. Yang,et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.
[8] L. Velloso,et al. Hippocampal Function Is Impaired by a Short-Term High-Fat Diet in Mice: Increased Blood–Brain Barrier Permeability and Neuroinflammation as Triggering Events , 2021, Frontiers in Neuroscience.
[9] I. Appollonio,et al. Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery? , 2021, Diagnostics.
[10] M. De la Fuente. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease. , 2021, Journal of Alzheimer's disease : JAD.
[11] F. Saravia,et al. Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease , 2021, Frontiers in Neuroscience.
[12] J. Kipnis,et al. Neuromodulation by the immune system: a focus on cytokines , 2021, Nature Reviews Immunology.
[13] P. González,et al. "Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials". , 2021, Pharmacological research.
[14] D. Weaver. Amyloid beta is an early responder cytokine and immunopeptide of the innate immune system , 2020, Alzheimer's & dementia.
[15] M. Emoto,et al. Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort , 2020, Journal of atherosclerosis and thrombosis.
[16] P. Oliver,et al. ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease , 2020, Antioxidants.
[17] J. Lukens,et al. The role of innate immunity in Alzheimer's disease , 2020, Immunological reviews.
[18] S. Bakker,et al. Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[19] M. De la Fuente,et al. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[20] K. Abe,et al. Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements , 2020, International journal of molecular sciences.
[21] S. Papageorgiou,et al. Current and Future Treatments in Alzheimer Disease: An Update , 2020, Journal of central nervous system disease.
[22] A. A. de Castro,et al. Future Therapeutic Perspectives into the Alzheimer’s Disease Targeting the Oxidative Stress Hypothesis , 2019, Molecules.
[23] D. Holtzman,et al. Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.
[24] C. Loreto,et al. Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model , 2019, Journal of Neuroinflammation.
[25] T. Littlejohns,et al. Association of Lifestyle and Genetic Risk With Incidence of Dementia. , 2019, JAMA.
[26] P. Newhouse,et al. The Role of Estrogen in Brain and Cognitive Aging , 2019, Neurotherapeutics.
[27] M. Cosentino,et al. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease. , 2019, Current medicinal chemistry.
[28] Roberta Diaz Brinton,et al. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan , 2019, Front. Endocrinol..
[29] B. Schöttker,et al. Oxidative stress and epigenetic mortality risk score: associations with all-cause mortality among elderly people , 2019, European Journal of Epidemiology.
[30] S. Hébert,et al. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease , 2019, Journal of Neuroinflammation.
[31] A. Angiolillo,et al. Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression? , 2018, Journal of Neuroinflammation.
[32] A. Caccamo,et al. Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice , 2018, Aging cell.
[33] R. Lathe,et al. The antimicrobial protection hypothesis of Alzheimer's disease , 2018, Alzheimer's & Dementia.
[34] B. Lamb,et al. Inflammation as a central mechanism in Alzheimer's disease , 2018, Alzheimer's & dementia.
[35] W. Petri,et al. The Impact of Systemic Inflammation on Neurodevelopment. , 2018, Trends in molecular medicine.
[36] M. D. Giudice,et al. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters , 2018, Brain, Behavior, and Immunity.
[37] D. Bailey,et al. 13 reasons why the brain is susceptible to oxidative stress , 2018, Redox biology.
[38] M. De la Fuente,et al. Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress , 2018, Front. Immunol..
[39] V. Gotta,et al. Cytokine profiling in healthy children shows association of age with cytokine concentrations , 2017, Scientific Reports.
[40] Alan J. Thomas,et al. Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[41] M. Grobusch,et al. Influence of Age and Other Factors on Cytokine Expression Profiles in Healthy Children—A Systematic Review , 2017, Front. Pediatr..
[42] M. Fernández-Fernández,et al. Hsp70 – a master regulator in protein degradation , 2017, FEBS letters.
[43] A. Carvalho,et al. Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.
[44] R. Thangavel,et al. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration , 2017, Front. Cell. Neurosci..
[45] G. Gigli,et al. Serum Interleukin-10 Levels Correlate with Cerebrospinal Fluid Amyloid Beta Deposition in Alzheimer Disease Patients , 2017, Neurodegenerative Diseases.
[46] M. De la Fuente,et al. An Appropriate Modulation of Lymphoproliferative Response and Cytokine Release as Possible Contributors to Longevity , 2017, International journal of molecular sciences.
[47] Hyun Kim,et al. Serum tumour necrosis factor‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairment , 2017, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.
[48] C. Borlongan,et al. When friend turns foe: central and peripheral neuroinflammation in central nervous system injury , 2017, Neuroimmunology and neuroinflammation.
[49] K. Suk,et al. Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis , 2017, Journal of the Neurological Sciences.
[50] S. Allan,et al. Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection , 2017, Journal of Neuroinflammation.
[51] M. Baquero,et al. Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease , 2017, Journal of the Neurological Sciences.
[52] E. Ortega,et al. Hsp70 basal levels, a tissue marker of the rate of aging and longevity in mice , 2016, Experimental Gerontology.
[53] Zhijun Zhang,et al. Inflammatory Cytokines and Alzheimer’s Disease: A Review from the Perspective of Genetic Polymorphisms , 2016, Neuroscience Bulletin.
[54] Jennifer K. Blakemore,et al. Aromatase: Contributions to Physiology and Disease in Women and Men. , 2016, Physiology.
[55] Xiaoling Zhou,et al. An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels. , 2016, American journal of translational research.
[56] M. De la Fuente,et al. The role of Hsp70 in oxi-inflamm-aging and its use as a potential biomarker of lifespan , 2015, Biogerontology.
[57] J. Chan,et al. Peripheral inflammation increases seizure susceptibility via the induction of neuroinflammation and oxidative stress in the hippocampus , 2015, Journal of Biomedical Science.
[58] H. Brenner,et al. Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.
[59] D. Talwar,et al. Systemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study , 2015, PloS one.
[60] James A. Eddy,et al. IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior , 2015, Neuron.
[61] M. Guillot-Sestier,et al. Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.
[62] J. Cruces,et al. Function and redox state of peritoneal leukocytes as preclinical and prodromic markers in a longitudinal study of triple-transgenic mice for Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[63] I. Aleksic,et al. Peritoneal exudate cells from long-lived rats exhibit increased IL-10/IL-1β expression ratio and preserved NO/urea ratio following LPS-stimulation in vitro , 2014, AGE.
[64] Antonio Ayala,et al. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.
[65] M. Heneka,et al. Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview , 2014, Molecular Neurobiology.
[66] A. Reiner,et al. Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[67] Michael W. Weiner,et al. The future of blood-based biomarkers for Alzheimer's disease , 2014, Alzheimer's & Dementia.
[68] M. Alberoni,et al. A complex proinflammatory role for peripheral monocytes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[69] R. Morishita,et al. Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model , 2013, Neurobiology of Aging.
[70] Jung-Eun Lee,et al. An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions , 2013, Experimental neurobiology.
[71] L. Monasta,et al. Cytokine Levels in the Serum of Healthy Subjects , 2013, Mediators of inflammation.
[72] C. Holmes. Review: Systemic inflammation and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.
[73] A. Boveris,et al. Lipid Peroxidation: Chemical Mechanism, Biological Implications and Analytical Determination , 2012 .
[74] M. D. Mayas,et al. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia , 2012, Experimental Gerontology.
[75] M. De la Fuente,et al. Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease , 2012, Annals of the New York Academy of Sciences.
[76] H. Besedovsky,et al. Hsp72, inflammation, and aging: causes, consequences, and perspectives , 2012, Annals of the New York Academy of Sciences.
[77] G. Ricevuti,et al. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. , 2011, Autoimmunity reviews.
[78] D. Butterfield,et al. Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. , 2011, Biochimica et biophysica acta.
[79] C. Meisinger,et al. Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study , 2011, AGE.
[80] I. Grundke‐Iqbal,et al. Alzheimer's disease, a multifactorial disorder seeking multitherapies , 2010, Alzheimer's & Dementia.
[81] R. Dyck,et al. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes , 2010, Brain Research.
[82] K. Duan,et al. Inflammation: a bridge between postoperative cognitive dysfunction and Alzheimer's disease. , 2010, Medical hypotheses.
[83] Bengt Winblad,et al. Biomarkers for Alzheimer’s disease and other forms of dementia: Clinical needs, limitations and future aspects , 2010, Experimental Gerontology.
[84] O. Forlenza,et al. Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment , 2009, Dementia and Geriatric Cognitive Disorders.
[85] M. Eyrich,et al. Age-related changes in intracellular cytokine expression in healthy children. , 2009, European cytokine network.
[86] J. Sayre,et al. Immune blood biomarkers of Alzheimer disease patients , 2009, Journal of Neuroimmunology.
[87] M. Block,et al. NADPH oxidase as a therapeutic target in Alzheimer's disease , 2008, BMC Neuroscience.
[88] M. De la Fuente,et al. Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity , 2008, Neuroimmunomodulation.
[89] P. Moreira,et al. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. , 2008, Free radical biology & medicine.
[90] P. Gil,et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease. , 2008, Immunology letters.
[91] A. Lewandowska,et al. Chaperones in control of protein disaggregation , 2008, The EMBO journal.
[92] J. Dayer,et al. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors , 2007, Arthritis research & therapy.
[93] Claudius Mueller,et al. Increased production of inflammatory cytokines in mild cognitive impairment , 2007, Experimental Gerontology.
[94] N. Kraut,et al. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition , 2007, Proteomics.
[95] H. Besedovsky,et al. Physiology of psychoneuroimmunology: A personal view , 2007, Brain, Behavior, and Immunity.
[96] B. Brenner,et al. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. , 2006, Kidney international.
[97] A. Chauhan,et al. Oxidative stress in Alzheimer's disease. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.
[98] V. Mathura,et al. Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease , 2005, Journal of Neuroinflammation.
[99] S. Levison,et al. Interleukin‐1: A master regulator of neuroinflammation , 2004, Journal of neuroscience research.
[100] J. Streffer,et al. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy , 2004, Molecular Psychiatry.
[101] F. LaFerla,et al. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.
[102] I. Appollonio,et al. Peripheral cytokine release in Alzheimer patients: correlation with disease severity , 2003, Neurobiology of Aging.
[103] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[104] H. Cohen,et al. Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.
[105] Virginia M. Y. Lee,et al. Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.
[106] A K Manatunga,et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.
[107] J. Barnes,et al. Oxidative signalling and inflammatory pathways in Alzheimer's disease. , 2001, Biochemical Society symposium.
[108] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[109] J. Chipeta,et al. CD4+ and CD8+ cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. , 1998, Cellular immunology.
[110] R. Hendricks,et al. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. , 1997, Journal of immunology.
[111] H. Besedovsky,et al. Immune-neuro-endocrine interactions: facts and hypotheses. , 1996, Endocrine reviews.
[112] S. Araga,et al. Serum interleukin‐2 levels in patients with dementia of the Alzheimer type , 1991, Acta neurologica Scandinavica.
[113] R. Hilf,et al. A fluorometric method for determination of oxidized and reduced glutathione in tissues. , 1976, Analytical biochemistry.
[114] M. De la Fuente,et al. Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.
[115] M. Fuente. Oxidation and Inflammation in the Immune and Nervous Systems, a Link Between Aging and Anxiety , 2018 .
[116] M. Rey. Bio-Psycho-Social Bridge: The Psychoneuroimmune System in Successful Aging , 2018 .
[117] H. Besedovsky,et al. Immune-Neuro-Endocrine Reflexes, Circuits, and Networks: Physiologic and Evolutionary Implications. , 2017, Frontiers of hormone research.
[118] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[119] H. Besedovsky,et al. Central and Peripheral Cytokines Mediate Immune-Brain Connectivity , 2010, Neurochemical Research.
[120] M. D. de Leon,et al. Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. , 2008, Journal of Alzheimer's disease : JAD.
[121] A. Valentine,et al. Neurobehavioral effects of interferon therapy , 2005, Current psychiatry reports.
[122] H. Feldman,et al. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[123] J. Whittum-Hudson,et al. Infectious agents and Alzheimer's Disease. , 2003 .
[124] A. Valenzuela,et al. The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. , 1991, Life sciences.